Identification of acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 11, 2014, Pages 6360-6370

  Blanchard, Catlyn ^a   Barnett, Pamela ^a   Perlmutter, Jessamyn ^a   Dunman, Paul M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CALCIUM ION; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; LEVOFLOXACIN; NALIDIXIC ACID; POLYMYXIN B; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG; [ 4 [(4 CHLOROBENZYLIDENE)AMINO]BENEZENESULFONAMIDE]; [N TERT BUTYL 2 (1 TERT BUTYLTETRAZOL 5 YL)SULFANYLACETAMIDE]; ACETAMIDE DERIVATIVE; ACINETOBACTER BAUMANNII EFFLUX PUMP INHIBITOR 1; ACINETOBACTER BAUMANNII EFFLUX PUMP INHIBITOR 2; ANTIINFECTIVE AGENT; CALCIUM CHANNEL; CARRIER PROTEIN; MEROPENEM; MINOCYCLINE; SULFONAMIDE; TETRACYCLINE; TETRAZOLE DERIVATIVE; THIENAMYCIN DERIVATIVE; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY ASSAY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG TOLERANCE; GRAM NEGATIVE INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PSEUDOMONAS AERUGINOSA; TISSUE SCAFFOLD; ACINETOBACTER INFECTIONS; ANALOGS AND DERIVATIVES; BLOOD; CELL LINE; DRUG EFFECTS; ENZYMOLOGY; HEK293 CELL LINE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; TRANSPORT AT THE CELLULAR LEVEL;

ACETAMIDES; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; CALCIUM CHANNELS; CELL LINE; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HEK293 CELLS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PSEUDOMONAS AERUGINOSA; SULFONAMIDES; TETRACYCLINE; TETRAZOLES; THIENAMYCINS;

EID: 84908628086     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03535-14     Document Type: Article

References (42)

1. Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E, Aldabó-Pallás T, Cayuela A, Marquez-Vácaro JA, Garcia-Curiel A, Jiménez-Jiménez FJ. 2005. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med. 31: 649-655. http://dx.doi.org/10.1007/s00134-005-2598-0.
2. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
3. Roca I, Espinal P, Vila-Farrés X, Vila J. 2012. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drugresistant menace. Front. Microbiol. 3:148. http://dx.doi.org/10.3389/fmicb .2012.00148.
4. Simmonds A, Munoz J, Aguero-Rosenfeld M, Carbonaro C, Montecalvo M, Clones B, LaGamma EF. 2009. Outbreak of Acinetobacter infection in extremely low birth weight neonates. Pediatr. Infect. Dis. J. 28:210-214. http://dx.doi.org/10.1097/INF.0b013e31818cb0aa.
5. Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A. 2007. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis. 13:97-103. http://dx.doi.org/10.3201/eid1301.060716.
6. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317. http://dx.doi.org/10.1086/421946.
7. Doi Y, Husain S, Potoski BA, McCurry KR, Paterson DL. 2009. Extensively drug-resistant Acinetobacter baumannii. Emerg. Infect. Dis. 15:980-982. http://dx.doi.org/10.3201/eid1506.081006.
8. Grosso F, Quinteira S, Peixe L. 2010. Emergence of an extreme-drugresistant (XDR) Acinetobacter baumannii carrying blaOXA-23 in a patient with acute necrohaemorrhagic pancreatitis. J. Hosp. Infect. 75:82-83. http://dx.doi.org/10.1016/j.jhin.2010.01.007.
9. Hampton T. 2013. Report reveals scope of U.S. antibiotic resistance threat. JAMA 310:1661-1663. http://dx.doi.org/10.1001/jama.2013.280695.
10. Tan SY, Chua SL, Liu Y, Høiby N, Andersen LP, Givskov M, Song Z, Yang L. 2013. Comparative genomic analysis of rapid evolution of an extreme-drug-resistant Acinetobacter baumannii clone. Genome Biol. Evol. 5:807-818. http://dx.doi.org/10.1093/gbe/evt047.
11. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrugresistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 50:4114-4123. http://dx.doi.org/10.1128/AAC.00778-06.
12. Rumbo C, Gato E, López M, Ruiz de Alegría C, Fernández-Cuenca F, Martínez-Martínez L, Vila J, Pachón J, Cisneros JM, Rodríguez-Bano J, Pascual A, Bou G, Tomas M. 2013. Contribution of efflux pumps, porins, and -lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 57:5247-5257. http://dx.doi.org/10.1128/AAC.00730-13.
13. Rajamohan G, Srinivasan VB, Gebreyes WA. 2010. Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 65:1919-1925. http://dx.doi.org/10.1093/jac/dkq195.
14. Roca I, Marti S, Espinal P, Martínez P, Gibert I, Vila J. 2009. CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:4013-4014. http://dx.doi.org/10.1128/AAC.00584-09.
15. Su XZ, Chen J, Mizushima T, Kuroda T, Tsuchiya T. 2005. AbeM, an H-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob. Agents Chemother. 49: 4362-4364. http://dx.doi.org/10.1128/AAC.49.10.4362-4364.2005.
16. Srinivasan VB, Rajamohan G, Gebreyes WA. 2009. Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:5312-5316. http://dx.doi.org/10.1128/AAC.00748-09.
17. Cortez-Cordova J, Kumar A. 2011. Activity of the efflux pump inhibitor phenylalanine-arginine -naphthylamide against the AdeFGH pump of Acinetobacter baumannii. Int. J. Antimicrob. Agents 37:420-424. http://dx.doi.org/10.1016/j.ijantimicag.2011.01.006.
18. Coyne S, Rosenfeld N, Lambert T, Courvalin P, Périchon B. 2010. Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:4389-4393. http://dx.doi.org/10.1128/AAC.00155-10.
19. Damier-Piolle L, Magnet S, Brémont S, Lambert T, Courvalin P. 2008. AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob. Agents Chemother. 52: 557-562. http://dx.doi.org/10.1128/AAC.00732-07.
20. Hornsey M, Ellington MJ, Doumith M, Thomas CP, Gordon NC, Wareham DW, Quinn J, Lolans K, Livermore DM, Woodford N. 2010. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J. Antimicrob. Chemother. 65:1589-1593. http://dx.doi.org/10.1093/jac/dkq218.
21. Wieczorek P, Sacha P, Hauschild T, Zórawski M, Krawczyk M, Tryniszewska E. 2008. Multidrug-resistant Acinetobacter baumannii-the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Folia Histochem. Cytobiol. 46:257-267. http://dx.doi.org/10.2478/v10042-008-0056-x.
22. Coyne S, Courvalin P, Périchon B. 2011. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob. Agents Chemother. 55:947-953. http://dx.doi.org/10.1128/AAC.01388-10.
23. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H, Robert C, Mangenot S, Abergel C, Nordmann P, Weissenbach J, Raoult D, Claverie JM. 2006. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2:e7. http://dx.doi.org/10.1371/journal.pgen.0020007.
24. Hood MI, Jacobs AC, Sayood K, Dunman PM, Skaar EP. 2010. Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations. Antimicrob. Agents Chemother. 54:1029-1041. http://dx.doi.org/10.1128/AAC.00963-09.
25. Jacobs AC, Sayood K, Olmsted SB, Blanchard CE, Hinrichs S, Russell D, Dunman PM. 2012. Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes. FEMS Immunol. Med. Microbiol. 64:403-412. http://dx.doi.org/10.1111/j.1574-695X.2011.00926.x.
26. Fernández L, Hancock RE. 2012. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin. Microbiol. Rev. 25:661-681. http://dx.doi.org/10.1128/CMR.00043-12.
27. Jacobs AC, Hood I, Boyd KL, Olson PD, Morrison JM, Carson S, Sayood K, Iwen PC, Skaar EP, Dunman PM. 2010. Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect. Immun. 78:1952-1962. http://dx.doi.org/10.1128/IAI.00889-09.
28. Holloway BW, Morgan AF. 1986. Genome organization in Pseudomonas. Annu. Rev. Microbiol. 40:79-105. http://dx.doi.org/10.1146/annurev.mi .40.100186.000455.
29. Cai H, Rose K, Liang LH, Dunham S, Stover C. 2009. Development of a liquid chromatography/mass spectrometry-based drug accumulation assay in Pseudomonas aeruginosa. Anal. Biochem. 385:321-325. http://dx.doi.org/10.1016/j.ab.2008.10.041.
30. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, Blais J, Cho D, Chamberland S, Renau T, Leger R, Hecker S, Watkins W, Hoshino K, Ishida H, Lee VJ. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116. http://dx.doi.org/10.1128/AAC.45.1.105-116.2001.
31. Magnet S, Courvalin P, Lambert T. 2001. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45: 3375-3380. http://dx.doi.org/10.1128/AAC.45.12.3375-3380.2001.
32. Marchand I, Damier-Piolle L, Courvalin P, Lambert T. 2004. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob. Agents Chemother. 48: 3298-3304. http://dx.doi.org/10.1128/AAC.48.9.3298-3304.2004.
33. Peleg AY, Adams J, Paterson DL. 2007. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:2065-2069. http://dx.doi.org/10.1128/AAC.01198-06.
34. Watkins WJ, Landaverry Y, Léger R, Litman R, Renau TE, Williams N, Yen R, Zhang JZ, Chamberland S, Madsen D, Griffith D, Tembe V, Huie K, Dudley MN. 2003. The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors. Bioorg. Med. Chem. Lett. 13:4241-4244. http://dx.doi.org/10.1016/j.bmcl.2003.07.030.
35. Koh JY, Cotman CW. 1992. Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists. Brain Res. 587:233-240. http://dx.doi.org/10.1016/0006-8993(92)91002-V.
36. Rice LB. 2008. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 197:1079-1081. http://dx.doi.org/10.1086/533452.
37. Howard A, O'Donoghue M, Feeney A, Sleator RD. 2012. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 3:243-250. http://dx.doi.org/10.4161/viru.19700.
38. Choi CH, Lee JS, Lee YC, Park TI, Lee JC. 2008. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol. 8:216. http://dx.doi.org/10.1186/1471-2180-8-216.
39. Kim SW, Choi CH, Moon DC, Jin JS, Lee JH, Shin JH, Kim JM, Lee YC, Seol SY, Cho DT, Lee JC. 2009. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol. Lett. 301:224-231. http://dx.doi.org/10.1111/j.1574-6968 .2009.01820.x.
40. Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA. 2010. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect. Immun. 78:3993-4000. http://dx.doi.org/10.1128/IAI .00366-10.
41. Russo TA, MacDonald U, Beanan JM, Olson R, MacDonald IJ, Sauberan SL, Luke NR, Schultz LW, Umland TC. 2009. Penicillinbinding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. J. Infect. Dis. 199:513-521. http://dx.doi.org/10.1086/596317.
42. Winum JY, Scozzafava A, Montero JL, Supuran CT. 2006. Therapeutic potential of sulfamides as enzyme inhibitors. Med. Res. Rev. 26:767-792. http://dx.doi.org/10.1002/med.20068.